Health and Fitness Health and Fitness
Tue, September 14, 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Alexion to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence
[ Tue, Sep 14th 2010 ] - Market Wire
Guided Therapeutics Completes $3 Million Financing
[ Tue, Sep 14th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Unigene CEO Presents New Strategy and Corporate R .. odman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals interverr al Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals effectuera une pr©sentat .. 10 de Roche Colorado Corporation sur les peptides
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals aanwezig op Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Zalicus To Present at the Rodman & Renshaw Annual Global Investment Conference NYC
[ Tue, Sep 14th 2010 ] - Market Wire
CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS
[ Tue, Sep 14th 2010 ] - Market Wire
Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer
[ Tue, Sep 14th 2010 ] - Market Wire
AngioDynamics Strengthens Executive Team with Key Appointments
Mon, September 13, 2010
[ Mon, Sep 13th 2010 ] - Market Wire
aQuada HIV-kuur in ©©n tablet van Gilead handha .. suppressie gedurende 48 weken in fase-2 onderzoek
[ Mon, Sep 13th 2010 ] - Market Wire
Ironwood Pharmaceuticals Announces Conference Cal .. iscuss Positive Linaclotide Phase 3 IBS-C Results
[ Mon, Sep 13th 2010 ] - Market Wire
Ironwood and Forest Announce Positive Linaclotide .. n Patients with Irritable Bowel Syndrome with Con
[ Mon, Sep 13th 2010 ] - Market Wire
Aetna Reminds Members Affected by the San Bruno Fire Where to Call for Help
[ Mon, Sep 13th 2010 ] - Market Wire
MEDNAX to Present at Stifel Nicolaus 2010 Healthcare Conference
[ Mon, Sep 13th 2010 ] - Market Wire
Benjamin A. Breier Named to Modern Healthcarea?s aUp & Comersa List
[ Mon, Sep 13th 2010 ] - Market Wire
Almirall and Ironwood Announce Positive Results f .. clotide in Patients with Irritable Bowel Syndrome
[ Mon, Sep 13th 2010 ] - Market Wire
WellCare to Participate in Stifel Nicolaus 2010 Healthcare Conference
[ Mon, Sep 13th 2010 ] - Market Wire
AGA Medical to Present at the UBS Global Life Sciences Conference
[ Mon, Sep 13th 2010 ] - Market Wire
Gilead Sciences to Present at the UBS Global Life Sciences Conference on Monday, September 20
[ Mon, Sep 13th 2010 ] - Market Wire
Flamel Technologies to Present at the UBS Global Life Sciences Conference in New York
[ Mon, Sep 13th 2010 ] - Market Wire
DIAGNOCURE ANNOUNCES THIRD QUARTER 2010 RESULTS
[ Mon, Sep 13th 2010 ] - Market Wire
Molina Healthcare Issues Revised Guidance for Its 2010 Fiscal Year
[ Mon, Sep 13th 2010 ] - Market Wire
Angeion Corporation Announces Increase in Stock Repurchase Program
[ Mon, Sep 13th 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. ntation at Robert W. Baird Health Care Conference

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Health Care Conference


Published on 2010-09-13 13:10:17 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ:HGSI) announced today that its presentation at the Robert W. Baird 2010 Health Care Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa™ senior management team will present a corporate overview on Wednesday, September 15, 2010, at 2:45 PM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

For more information about HGS, please visit the Companya™s web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ medinfo@hgsi.com ] or by calling HGS at (877) 822-8472.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.

Contributing Sources